B9-- you think Dr.McGann wants to do all of that? I hope he does, but building amazing products seems to be his wheelhouse. Now he has to find money, alot of money and he has about a month before this dissolves into French air. Which is odd, as McGann left Morpho to consult with IMSC, so if he is on good relations, maybe the French step in with a fairly valued buy out.
As you point out, $2+ is the mark that takes this home. And 115M shares was the fully diluted mark, so $250M for a pending IDIQ, an IP library to kill for, a TSA R/D grant and a product line that many many X-rayers need might appear out of thin air.
$2+ was not the vision I had for may investment in IMSC ....
News 
Market Data 
Discover 
AI
